Review of Maximizing Drug Discounts Under the Missouri Ryan White Program

EXECUTIVE SUMMARY:

This final audit report addressed the adequacy of procedures used by Missouri for effectively maximizing available discount drug pricing programs. We compared drug prices obtained from the Department of Health under the Ryan White Care Act, Title II (Title II) and the AIDS Drug Assistance Program Programs (ADAP) with drug prices obtained from the Department of Social Services under the Medicaid program. The review covered drugs totaling $270,335 paid during the period April 1, 1996 through December 31, 1996. Generally, we found that drug prices under Title II and ADAP were comparable to drug prices under Medicaid. No formal recommendations were made at this time, however, because the programs are expanding, we believe the State should continue to monitor drug prices to minimize future drug costs.